Bio-View Ltd (BIOV.TA)
ILA 29.4
(0.0%)
ILA 29.4
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 20.61 Million ILS | 25.22% |
| 2022 | 16.56 Million ILS | 18.04% |
| 2021 | 14.03 Million ILS | 3.1% |
| 2020 | 13.61 Million ILS | -14.43% |
| 2019 | 15.9 Million ILS | -8.53% |
| 2018 | 17.39 Million ILS | 3.16% |
| 2017 | 16.86 Million ILS | 2.73% |
| 2016 | 16.41 Million ILS | -6.8% |
| 2015 | 17.61 Million ILS | -2.5% |
| 2014 | 18.06 Million ILS | 16.3% |
| 2013 | 15.53 Million ILS | 2.19% |
| 2012 | 15.19 Million ILS | 9.42% |
| 2011 | 13.88 Million ILS | 23.55% |
| 2010 | 11.24 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5 Million ILS | 0.0% |
| 2024 Q1 | 5 Million ILS | -15.37% |
| 2023 Q4 | 5.91 Million ILS | -0.85% |
| 2023 FY | 20.74 Million ILS | 25.22% |
| 2023 Q3 | 5.96 Million ILS | 35.7% |
| 2023 Q2 | 4.39 Million ILS | 0.0% |
| 2023 Q1 | 4.39 Million ILS | -0.62% |
| 2022 Q2 | 4.39 Million ILS | 24.21% |
| 2022 FY | 16.56 Million ILS | 18.04% |
| 2022 Q4 | 4.42 Million ILS | 7.83% |
| 2022 Q3 | 4.1 Million ILS | -6.75% |
| 2022 Q1 | 3.54 Million ILS | 18.83% |
| 2021 Q2 | 3.37 Million ILS | 15.82% |
| 2021 Q1 | 2.91 Million ILS | -8.51% |
| 2021 FY | 14.03 Million ILS | 3.1% |
| 2021 Q3 | 4.17 Million ILS | 23.56% |
| 2021 Q4 | 2.97 Million ILS | -28.56% |
| 2020 FY | 13.61 Million ILS | -14.43% |
| 2020 Q4 | 3.18 Million ILS | -0.84% |
| 2020 Q2 | 3.08 Million ILS | -25.28% |
| 2020 Q3 | 3.21 Million ILS | 4.08% |
| 2020 Q1 | 4.13 Million ILS | 4.06% |
| 2019 Q4 | 3.96 Million ILS | 4.15% |
| 2019 FY | 15.9 Million ILS | -8.53% |
| 2019 Q3 | 3.81 Million ILS | -4.05% |
| 2019 Q1 | 4.15 Million ILS | -4.92% |
| 2019 Q2 | 3.97 Million ILS | -4.45% |
| 2018 Q3 | 4.04 Million ILS | -13.13% |
| 2018 FY | 17.39 Million ILS | 3.16% |
| 2018 Q1 | 4.32 Million ILS | -7.15% |
| 2018 Q2 | 4.65 Million ILS | 7.73% |
| 2018 Q4 | 4.37 Million ILS | 8.11% |
| 2017 Q2 | 4.32 Million ILS | 0.0% |
| 2017 FY | 16.86 Million ILS | 2.73% |
| 2017 Q4 | 4.65 Million ILS | 0.0% |
| 2017 Q3 | 4.65 Million ILS | 7.57% |
| 2017 Q1 | 4.32 Million ILS | 18.52% |
| 2016 Q1 | 4.27 Million ILS | -5.44% |
| 2016 FY | 16.41 Million ILS | -6.8% |
| 2016 Q4 | 3.65 Million ILS | -18.62% |
| 2016 Q3 | 4.48 Million ILS | 12.04% |
| 2016 Q2 | 4 Million ILS | -6.34% |
| 2015 Q2 | 4.54 Million ILS | -1.88% |
| 2015 Q1 | 4.63 Million ILS | -8.38% |
| 2015 Q3 | 3.91 Million ILS | -13.97% |
| 2015 FY | 17.61 Million ILS | -2.5% |
| 2015 Q4 | 4.52 Million ILS | 15.57% |
| 2014 Q2 | 4.09 Million ILS | -10.19% |
| 2014 FY | 18.06 Million ILS | 16.3% |
| 2014 Q4 | 5.05 Million ILS | 16.36% |
| 2014 Q1 | 4.56 Million ILS | 7.87% |
| 2014 Q3 | 4.34 Million ILS | 6.08% |
| 2013 Q1 | 4.39 Million ILS | 0.0% |
| 2013 Q2 | 3.84 Million ILS | -12.47% |
| 2013 Q3 | 3.59 Million ILS | -6.58% |
| 2013 Q4 | 4.22 Million ILS | 17.67% |
| 2013 FY | 15.53 Million ILS | 2.19% |
| 2012 FY | 15.19 Million ILS | 9.42% |
| 2011 FY | 13.88 Million ILS | 23.55% |
| 2010 FY | 11.24 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|